<VariationArchive VariationID="832219" VariationName="NC_000019.10:g.(?_13300530)_(13300676_?)del" VariationType="Deletion" Accession="VCV000832219" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="821242" VariationID="832219">
      <GeneList>
        <Gene Symbol="CACNA1A" FullName="calcium voltage-gated channel subunit alpha1 A" GeneID="773" HGNC_ID="HGNC:1388" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13206442" stop="13506479" display_start="13206442" display_stop="13506479" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13317255" stop="13617273" display_start="13317255" display_stop="13617273" Strand="-" />
          </Location>
          <OMIM>601011</OMIM>
          <Haploinsufficiency last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000019.10:g.(?_13300530)_(13300676_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" innerStart="13411344" innerStop="13411490" display_start="13411344" display_stop="13411490" variantLength="147" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.(?_13411344)_(13411490_?)del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.(?_13411344)_(13411490_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000019.10:g.(?_13300530)_(13300676_?)del AND multiple conditions" Accession="RCV001032730" Version="6">
        <ClassifiedConditionList TraitSetID="39917">
          <ClassifiedCondition DB="MedGen" ID="C4310716">Developmental and epileptic encephalopathy, 42</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1720416">Episodic ataxia type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-11-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-11-16" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10371528</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19486177</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25735478</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27250579</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="39917" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1620" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Episodic ataxia with nystagmus</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nystagmus-associated episodic ataxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Episodic ataxia type 2</ElementValue>
                <XRef ID="Episodic+Ataxia+with+Nystagmus/2620" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007163" DB="MONDO" />
                <XRef ID="420932006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebellopathy, hereditary paroxysmal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia, familial, paroxysmal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acetazolamide-responsive, hereditary, paroxysmal, cerebellar ataxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acetazolamide-responsive episodic ataxia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebellar ataxia, paroxysmal, Acetazolamide-responsive</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EA2</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">APCA</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CAPA</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9602" />
                <XRef ID="9602" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <XRef ID="97" DB="Orphanet" />
              <XRef ID="C1720416" DB="MedGen" />
              <XRef ID="MONDO:0007163" DB="MONDO" />
              <XRef Type="MIM" ID="108500" DB="OMIM" />
            </Trait>
            <Trait ID="36150" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 42</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 42</ElementValue>
                <XRef ID="MONDO:0014917" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE42</ElementValue>
                <XRef Type="MIM" ID="617106" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16191" />
                <XRef ID="16191" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C4310716" DB="MedGen" />
              <XRef ID="MONDO:0014917" DB="MONDO" />
              <XRef Type="MIM" ID="617106" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2357292" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="NM_001127221.1_19_Deletion (exon 18)|MedGen:C4310716;C1720416" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001196037" DateUpdated="2024-06-09" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10371528</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19486177</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25735478</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27250579</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CACNA1A are known to be pathogenic (PMID: 10371528, 19486177, 25735478, 27250579). This variant has not been reported in the literature in individuals with CACNA1A-related conditions. This variant is an out-of-frame deletion of the genomic region encompassing exon 18 of the CACNA1A gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CACNA1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.(?_13411344)_(13411490_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4310716" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1720416" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2357292" TraitType="Disease" MappingType="XRef" MappingValue="C1720416" MappingRef="MedGen">
        <MedGen CUI="C1720416" Name="Episodic ataxia type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2357292" TraitType="Disease" MappingType="XRef" MappingValue="C4310716" MappingRef="MedGen">
        <MedGen CUI="C4310716" Name="Developmental and epileptic encephalopathy, 42" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

